Multivariate Cox regression analysis revealed that among molecular alterations, both KRAS mutations and BRAF mutations significantly predicted worse overall survival in patients with advanced CRC (hazard ratio 2.12, p < 0.001, and hazard ratio 3.37, p < 0.001, respectively), consistent with the literature (Table 3). This evidence concerns the gene BRAF and colorectal carcinoma.